4.1 Article

Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy

期刊

JOURNAL OF NEUROSURGERY-PEDIATRICS
卷 4, 期 3, 页码 217-221

出版社

AMER ASSOC NEUROLOGICAL SURGEONS
DOI: 10.3171/2009.4.PEDS08444

关键词

intrathecal baclofen infusion device; epilepsy; hydrocephalus; neuroleptic malignant syndrome

向作者/读者索取更多资源

Neuroleptic malignant syndrome (NMS) is a potentially life-threatening entity characterized by hyperthermia, autonomic deregulation, decreased mental status, increased muscle tone. Find, frequently, by renal failure due to rhabdomyolysis Classically, it follows administration of antipsychotic medication. The authors report on 4 patients (2 children and 2 adults) in whom NMS Was diagnosed after a CNS insult No patient was receiving g antipsychotic medication The patients' hospital and elmic charts. radiographic data. and follow-up telephone conversations were reviewed retrospectively. All 4 patients islet. diagnostic criteria for NMS Three patients presented with shunt failure, and 1 patient had undergone a functional hemispherectomy 2 days earlier One patient with shunt failure received the diagnosis retrospectively All endoscopic third ventriculostomy alleviated his shunt failure and tie remain,; free if NMS. The other 2 patients underwent treatment for shunt failure. but NMS remained Those 2 patients and the one who had undergone hemispherectomy underwent a trial of intrathecal baclofen, and the NMS resolved Subsequently, an intrathecal baclofen infusion device was placed in all 3 patients, and the NMS resolved The 2 patients in shunt failure had a lumbar intrathecal baclofen infusion device The patient Who had Undergone hemispherectomy had all intracranial baclofen catheter. Neuroleptic malignant syndrome is a rare, life-threatening disorder that cart occur without the administration of neuroleplic medications Alleviation of any CNS instill is the first order of treatment. Some patients with persistent symptoms of NMS may benefit from intrathecal delivery of baclofen. (DOI 10.3171/2009.4.PED.S08444)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据